Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Neuroimage|October 22, 2003
Time-dependent neural activations related to recognition of people's names in emotional and neutral face-name associative learning: an fMRI studyTakashi Tsukiura, Masayuki Namiki, Toshikatsu Fujii, et al.
Digestive Diseases and Sciences|February 28, 2023
Impact of Traction Direction in Traction-Assisted Gastric Endoscopic Submucosal Dissection (with Videos)Mitsuru Nagata, Masayuki Namiki, Tomoaki Fujikawa, et al.
Surgical Endoscopy|August 20, 2025
Unidirectional versus direction-selectable traction device in gastric endoscopic submucosal dissection: a randomized controlled trialMitsuru Nagata, Masayuki Namiki, Tomoaki Fujikawa, et al.
Endoscopy|October 18, 2024
Prospective randomized trial comparing conventional and underwater endoscopic submucosal dissection for superficial colorectal neoplasmsMitsuru Nagata, Masayuki Namiki, Tomoaki Fujikawa, et al.
Investigational New Drugs|September 3, 2011
Eribulin mesylate in patients with refractory cancers: a Phase I studyToru Mukohara, Shunji Nagai, Hirofumi Mukai, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 26, 2017
Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase InhibitorZiad Hussein, Hitoshi Mizuo, Seiichi Hayato, et al.
Journal of Biochemistry|July 19, 2003
Constitutive expression of cytochrome p450 genes in newly established rat hepatic cell linesMasakuni Degawa, Masayuki Namiki, Naoki Yoshimoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltrationTomoya Yamashita, Seinosuke Kawashima, Masanori Ozaki, et al.
Cancer Science|January 25, 2018
E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I studyKen Ohmachi, Kiyoshi Ando, Michinori Ogura, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2012
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancerColm Farrell, Charles Schweizer, Jason Wustner, et al.
Pageof 3